Oct 07, 2025 4:15pm EDT ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles
Oct 06, 2025 4:10pm EDT ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
Oct 01, 2025 4:05pm EDT ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System
Sep 25, 2025 4:05pm EDT ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer
Sep 04, 2025 4:05pm EDT ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners
Aug 04, 2025 4:05pm EDT ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio
May 12, 2025 4:05pm EDT ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing